pharmaceutical investing Acerus Updates on Temporary Unavailability of NATESTO in Canada and South Korea
pharmaceutical investing VIDEO - Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis
Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application
pharmaceutical investing Acerus Announces Results of Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil
pharmaceutical investing Acerus Provides Update on Continuing Commercial and R&D Achievements for NATESTO®
pharmaceutical investing Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe
Goldgroup Announces Shareholder Approval of Arrangement with Gold Resource Corporation and Results of Annual General and Special Meeting
Freegold Drills 2.08 g/t Au over 62.1 m within 102.3 m of 1.67 g/t Au in Infill Drilling at Golden Summit
Metalsource Mining Expands Silver Hill District Through Strategic Land Acquisition as Exploration Footprint Continues to Grow
